US Stock MarketDetailed Quotes

PBYI Puma Biotechnology

Watchlist

3.040
+0.020+0.66%

Trading Nov 26 09:30 ET

149.23MMarket Cap6.47P/E (TTM)

Puma Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.98%11.04M

-68.84%1.03M

325.50%11.25M

270.65%27.01M

36.08%10.46M

-38.50%10.62M

123.76%3.3M

109.83%2.64M

-176.64%-15.83M

241.36%7.68M

Net income from continuing operations

250.53%20.32M

-313.03%-4.53M

-443.68%-4.82M

1,079,450.00%21.59M

318.84%12.27M

1,710.00%5.8M

-77.31%2.13M

141.17%1.4M

100.01%2K

-232.72%-5.61M

Operating gains losses

----

-99.99%1K

--0

Depreciation and amortization

0.07%2.88M

1.11%2.91M

0.66%2.9M

17.06%11.52M

17.77%2.89M

16.48%2.88M

16.86%2.88M

17.13%2.88M

-12.96%9.84M

-17.63%2.45M

Other non cash items

----

--7M

----

Change In working capital

-1,054.28%-14.16M

116.53%769K

338.65%10.68M

59.88%-17.85M

-720.94%-7.5M

-109.96%-1.23M

83.92%-4.65M

84.62%-4.47M

-3,299.24%-44.5M

107.15%1.21M

-Change in receivables

-1,243.78%-26.49M

-421.56%-3.34M

151.94%23.14M

-6.95%-8.37M

-56.09%-19.23M

-61.12%2.32M

90.79%-640K

67.41%9.19M

-30.77%-7.82M

-41.17%-12.32M

-Change in inventory

226.64%6.38M

47.89%-1.95M

-103.15%-20K

-198.88%-2.55M

-251.30%-1.4M

60.92%1.95M

-711.11%-3.74M

477.98%635K

170.67%2.58M

854.64%926K

-Change in prepaid assets

34.27%1M

506.72%968K

-52.76%411K

-65.36%820K

29.51%-559K

-60.87%747K

-168.39%-238K

-3.65%870K

-11.32%2.37M

-934.74%-793K

-Change in payables and accrued expense

232.23%5.67M

789.31%5.83M

22.40%-12.93M

81.13%-7.13M

7.76%13.16M

-223.13%-4.29M

103.48%655K

51.93%-16.66M

-977.62%-37.8M

265.51%12.21M

-Change in other current assets

100.35%5K

111.29%14K

-66.82%657K

176.54%1.52M

-35.99%1.08M

-881.77%-1.42M

96.61%-124K

1,176.09%1.98M

-162.05%-1.98M

41,925.00%1.68M

-Change in other current liabilities

-33.19%-309K

-29.04%-351K

-0.43%-234K

-2.06%-940K

18.80%-203K

-30.34%-232K

-28.91%-272K

17.38%-233K

18.78%-921K

9.09%-250K

-Change in other working capital

-33.55%-414K

-36.52%-400K

-40.00%-350K

-29.89%-1.2M

-39.02%-342K

-28.10%-310K

-23.63%-293K

-28.21%-250K

-30.13%-920K

---246K

Cash from discontinued investing activities

Operating cash flow

3.98%11.04M

-68.84%1.03M

325.50%11.25M

270.65%27.01M

36.08%10.46M

-38.50%10.62M

123.76%3.3M

109.83%2.64M

-176.64%-15.83M

241.36%7.68M

Investing cash flow

Cash flow from continuing investing activities

-97.68%259K

115.01%703K

-9.34%-19.08M

-369.21%-19.13M

31.19%-8.17M

39.76%11.18M

-334.50%-4.68M

-294.28%-17.45M

165.29%7.1M

-356.94%-11.87M

Net PPE purchase and sale

25.93%-20K

----

---140K

---45K

---27K

----

--0

Net intangibles purchase and sale

--0

-78.57%-12.5M

--0

---12.5M

---7M

Net investment purchase and sale

-97.51%279K

115.67%723K

-285.45%-19.08M

-145.98%-6.49M

-66.74%-8.13M

40.10%11.21M

-331.10%-4.62M

-155.11%-4.95M

229.62%14.1M

-205.45%-4.87M

Cash from discontinued investing activities

Investing cash flow

-97.68%259K

115.01%703K

-9.34%-19.08M

-369.21%-19.13M

31.19%-8.17M

39.76%11.18M

-334.50%-4.68M

-294.28%-17.45M

165.29%7.1M

-356.94%-11.87M

Financing cash flow

Cash flow from continuing financing activities

-11.18M

138.28%12.22M

121,650.00%2.43M

Net issuance payments of debt

---11.11M

----

--0

----

--0

----

Net common stock issuance

----

--0

----

--12.5M

--2.5M

Net other financing activities

---223K

----

99.09%-277K

-3,350.00%-69K

Cash from discontinued financing activities

Financing cash flow

---11.18M

---11.33M

--0

138.28%12.22M

121,650.00%2.43M

Net cash flow

Beginning cash position

10.61%69.24M

23.22%78.84M

10.01%86.68M

4.65%78.79M

4.77%84.39M

13.10%62.6M

-4.82%63.99M

4.65%78.79M

-22.74%75.29M

5.84%80.55M

Current changes in cash

-99.48%114K

-592.29%-9.6M

47.09%-7.83M

125.26%7.88M

229.90%2.29M

-13.53%21.79M

88.32%-1.39M

-83.53%-14.81M

115.79%3.5M

-115.56%-1.76M

End cash Position

-17.82%69.35M

10.61%69.24M

23.22%78.84M

10.01%86.68M

4.77%84.39M

13.10%62.6M

-4.82%63.99M

4.65%78.79M

Free cash flow

4.06%11.02M

-68.80%1.01M

214.09%11.25M

162.95%14.37M

1,424.16%10.41M

-38.65%10.59M

123.27%3.23M

63.35%-9.86M

-210.54%-22.83M

112.57%683K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.98%11.04M	-68.84%1.03M	325.50%11.25M	270.65%27.01M	36.08%10.46M	-38.50%10.62M	123.76%3.3M	109.83%2.64M	-176.64%-15.83M	241.36%7.68M
Net income from continuing operations	250.53%20.32M	-313.03%-4.53M	-443.68%-4.82M	1,079,450.00%21.59M	318.84%12.27M	1,710.00%5.8M	-77.31%2.13M	141.17%1.4M	100.01%2K	-232.72%-5.61M
Operating gains losses	----	----	----	----	----	----	----	----	-99.99%1K	--0
Depreciation and amortization	0.07%2.88M	1.11%2.91M	0.66%2.9M	17.06%11.52M	17.77%2.89M	16.48%2.88M	16.86%2.88M	17.13%2.88M	-12.96%9.84M	-17.63%2.45M
Other non cash items	----	----	----	----	----	----	----	----	--7M	----
Change In working capital	-1,054.28%-14.16M	116.53%769K	338.65%10.68M	59.88%-17.85M	-720.94%-7.5M	-109.96%-1.23M	83.92%-4.65M	84.62%-4.47M	-3,299.24%-44.5M	107.15%1.21M
-Change in receivables	-1,243.78%-26.49M	-421.56%-3.34M	151.94%23.14M	-6.95%-8.37M	-56.09%-19.23M	-61.12%2.32M	90.79%-640K	67.41%9.19M	-30.77%-7.82M	-41.17%-12.32M
-Change in inventory	226.64%6.38M	47.89%-1.95M	-103.15%-20K	-198.88%-2.55M	-251.30%-1.4M	60.92%1.95M	-711.11%-3.74M	477.98%635K	170.67%2.58M	854.64%926K
-Change in prepaid assets	34.27%1M	506.72%968K	-52.76%411K	-65.36%820K	29.51%-559K	-60.87%747K	-168.39%-238K	-3.65%870K	-11.32%2.37M	-934.74%-793K
-Change in payables and accrued expense	232.23%5.67M	789.31%5.83M	22.40%-12.93M	81.13%-7.13M	7.76%13.16M	-223.13%-4.29M	103.48%655K	51.93%-16.66M	-977.62%-37.8M	265.51%12.21M
-Change in other current assets	100.35%5K	111.29%14K	-66.82%657K	176.54%1.52M	-35.99%1.08M	-881.77%-1.42M	96.61%-124K	1,176.09%1.98M	-162.05%-1.98M	41,925.00%1.68M
-Change in other current liabilities	-33.19%-309K	-29.04%-351K	-0.43%-234K	-2.06%-940K	18.80%-203K	-30.34%-232K	-28.91%-272K	17.38%-233K	18.78%-921K	9.09%-250K
-Change in other working capital	-33.55%-414K	-36.52%-400K	-40.00%-350K	-29.89%-1.2M	-39.02%-342K	-28.10%-310K	-23.63%-293K	-28.21%-250K	-30.13%-920K	---246K
Cash from discontinued investing activities
Operating cash flow	3.98%11.04M	-68.84%1.03M	325.50%11.25M	270.65%27.01M	36.08%10.46M	-38.50%10.62M	123.76%3.3M	109.83%2.64M	-176.64%-15.83M	241.36%7.68M
Investing cash flow
Cash flow from continuing investing activities	-97.68%259K	115.01%703K	-9.34%-19.08M	-369.21%-19.13M	31.19%-8.17M	39.76%11.18M	-334.50%-4.68M	-294.28%-17.45M	165.29%7.1M	-356.94%-11.87M
Net PPE purchase and sale	25.93%-20K	----	----	---140K	---45K	---27K	----	----	--0	--0
Net intangibles purchase and sale	--0	--0	--0	-78.57%-12.5M	--0	--0	--0	---12.5M	---7M	---7M
Net investment purchase and sale	-97.51%279K	115.67%723K	-285.45%-19.08M	-145.98%-6.49M	-66.74%-8.13M	40.10%11.21M	-331.10%-4.62M	-155.11%-4.95M	229.62%14.1M	-205.45%-4.87M
Cash from discontinued investing activities
Investing cash flow	-97.68%259K	115.01%703K	-9.34%-19.08M	-369.21%-19.13M	31.19%-8.17M	39.76%11.18M	-334.50%-4.68M	-294.28%-17.45M	165.29%7.1M	-356.94%-11.87M
Financing cash flow
Cash flow from continuing financing activities	-11.18M			0	0	0			138.28%12.22M	121,650.00%2.43M
Net issuance payments of debt	---11.11M	----	----	--0	--0	--0	----	----	--0	----
Net common stock issuance	----	----	----	--0	----	----	----	----	--12.5M	--2.5M
Net other financing activities	---223K	----	----	----	----	----	----	----	99.09%-277K	-3,350.00%-69K
Cash from discontinued financing activities
Financing cash flow	---11.18M	---11.33M	--0	--0	--0	--0	--0	--0	138.28%12.22M	121,650.00%2.43M
Net cash flow
Beginning cash position	10.61%69.24M	23.22%78.84M	10.01%86.68M	4.65%78.79M	4.77%84.39M	13.10%62.6M	-4.82%63.99M	4.65%78.79M	-22.74%75.29M	5.84%80.55M
Current changes in cash	-99.48%114K	-592.29%-9.6M	47.09%-7.83M	125.26%7.88M	229.90%2.29M	-13.53%21.79M	88.32%-1.39M	-83.53%-14.81M	115.79%3.5M	-115.56%-1.76M
End cash Position	-17.82%69.35M	10.61%69.24M	23.22%78.84M	10.01%86.68M	10.01%86.68M	4.77%84.39M	13.10%62.6M	-4.82%63.99M	4.65%78.79M	4.65%78.79M
Free cash flow	4.06%11.02M	-68.80%1.01M	214.09%11.25M	162.95%14.37M	1,424.16%10.41M	-38.65%10.59M	123.27%3.23M	63.35%-9.86M	-210.54%-22.83M	112.57%683K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data